Dynavox Group AB header image

Dynavox Group AB

DYVOX

Equity

ISIN SE0017105620 / Valor 114900704

NASDAQ Nordic Exchange Stockholm, Equities (2026-10-30)
SEK 73.20-2.59%

Dynavox Group AB
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Dynavox Group AB is a Swedish technology company specializing in augmentative and alternative communication (AAC) solutions for individuals with speech and communication impairments. The company develops and manufactures speech-generating devices, software applications, and related accessories designed to facilitate effective communication for people with conditions such as autism, cerebral palsy, and other disabilities. Dynavox serves a global market, providing tailored solutions that enhance the independence and quality of life for its users. In addition to its product offerings, the company offers training and support services to ensure effective implementation and use of its technologies in various settings, including educational institutions, healthcare facilities, and home environments.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

-27.2%1Y
128%3Y
%5Y

Performance

48.4%1Y
45.7%3Y
45.2%5Y

Volatility

Market cap

790 M

Market cap (USD)

Daily traded volume (Shares)

173,990

Daily traded volume (Shares)

1 day high/low

/

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Omnicell Inc
Omnicell Inc Omnicell Inc Valor: 1275961
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.62%USD 36.65
Xenon Pharmaceuticals Inc
Xenon Pharmaceuticals Inc Xenon Pharmaceuticals Inc Valor: 25419823
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.35%USD 37.41
Trupanion Inc
Trupanion Inc Trupanion Inc Valor: 24738737
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.20%USD 30.13
Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB Valor: 2676862
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.45%SEK 490.20
Biogen Inc
Biogen Inc Biogen Inc Valor: 1720684
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.59%USD 253.62
Dr. Lal PathLabs Limited
Dr. Lal PathLabs Limited Dr. Lal PathLabs Limited Valor: 30691066
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.37%INR 1,906.30
PolyPeptide Group Ltd
PolyPeptide Group Ltd PolyPeptide Group Ltd Valor: 111076085
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.23%CHF 42.00
Summit Therapeutics Inc
Summit Therapeutics Inc Summit Therapeutics Inc Valor: 56903013
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.05%USD 16.03
BioArctic AB
BioArctic AB BioArctic AB Valor: 38514501
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.69%SEK 317.20
Essity AB
Essity AB Essity AB Valor: 36846754
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.82%SEK 279.50